The field of oncology treatments is advancing very fast with innovative therapies and approaches on the market every day. It can get very tricky to support these therapies from an IT perspective, which is what you will hear more about in this discussion. I spoke with Anish Patankar, SVP and GM of Elekta’s Oncology Software Solutions, and we discusses:

How to go about the US hospital market, 

Development in software for oncology treatments,

Challenges in scaling healthcare IT software across markets. 

Newsletter: https://fodh.substack.com/www.facesofdigitalhealth.com

Show notes: [00:00:00] Introduction to Elekta[00:02:00] Elekta's Global Presence[00:04:00] US Market Focus[00:06:00] Growth in Developing Countries[00:08:00] Segmentation and Technology Adoption in the US[00:10:00] Untapped Needs and Opportunities in the US[00:12:00] Elekta's Use of AI[00:14:00] Patient Feedback and Clinical Decision Making[00:18:00] Navigating Legacy Software in Healthcare IT[00:20:00] Modernization and Customer Satisfaction[00:22:00] Global Standardization and Regulation Challenges[00:24:00] Interoperability and Open Ecosystem[00:26:00] Future of Oncology Market Development: the interplay between medications and radiation, and the potential of theranostics.[00:28:00] Exciting Technologies in Healthcare Beyond Oncology: personalized healthcare, digital twins[00:30:00] Cautions for the Future: The critical debate on the balance between innovation speed and safety, particularly with generative AI.